EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Rainmed Medical's enterprise value is HK$-90.82 Mil.
Rainmed Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-118.00 Mil. Therefore, Rainmed Medical's EV-to-EBITDA for today is 0.77.
The historical rank and industry rank for Rainmed Medical's EV-to-EBITDA or its related term are showing as below:
HKSE:02297'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.22 Med: -0.2 Max: 1.57
Current: 0.77
During the past 4 years, the highest EV-to-EBITDA of Rainmed Medical was 1.57. The lowest was -7.22. And the median was -0.20.
HKSE:02297's EV-to-EBITDA is ranked better than 93.96% of 480
companies
in the Medical Devices & Instruments industry
Industry Median: 15.3
vs HKSE:02297: 0.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Rainmed Medical EV-to-EBITDA Historical Data
The historical data trend for Rainmed Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rainmed Medical's EV-to-EBITDA
For the Medical Devices subindustry, Rainmed Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainmed Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Rainmed Medical's EV-to-EBITDA falls into.
Rainmed Medical's current Enterprise Value is HK$-90.82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rainmed Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-118.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rainmed Medical (HKSE:02297) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Rainmed Medical's PE Ratio for today is calculated as:
Rainmed Medical's share price for today is HK$0.195.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rainmed Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Rainmed Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02297 has been successfully added to your